These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3334887)

  • 21. Animal behavior case of the month. Congo African Grey parrot examined because of feather picking and self-injurious behavior.
    Juarbe-Díaz SV
    J Am Vet Med Assoc; 2000 May; 216(10):1562-4. PubMed ID: 10825940
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment for late-onset obsessive-compulsive disorder with parkinsonism.
    Agarwal A; Biswas D; Sadhu R
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):331-6. PubMed ID: 18806237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
    Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
    J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine augmentation for refractory obsessive-compulsive disorder. A case report.
    Pasquini M; Garavini A; Biondi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):157-9. PubMed ID: 15610960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are gender differences in antiobsessional response related to different clomipramine metabolism?
    Mundo E; Pirola R; Bellodi L; Smeraldi E; Bareggi SR
    J Clin Psychopharmacol; 2002 Jun; 22(3):341-2. PubMed ID: 12006911
    [No Abstract]   [Full Text] [Related]  

  • 27. Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies.
    Hale AS; Procter AW; Bridges PK
    Br J Psychiatry; 1987 Aug; 151():213-7. PubMed ID: 3690111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obsessive-compulsive disorder.
    Insel TR
    Psychiatr Clin North Am; 1985 Mar; 8(1):105-17. PubMed ID: 3887336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of clomipramine in treatment of obsessive-compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study.
    Seksel K; Lindeman MJ
    Aust Vet J; 2001 Apr; 79(4):252-6. PubMed ID: 11349411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment.
    McCracken JT; Hanna GL
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):581-7. PubMed ID: 16190790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trazodone treatment in clomipramine-resistant obsessive-compulsive disorder.
    Hermesh H; Aizenberg D; Munitz H
    Clin Neuropharmacol; 1990 Aug; 13(4):322-8. PubMed ID: 2119885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research.
    Liebowitz MR; Fyer AJ; Gorman JM; Campeas RB; Sandberg DP; Hollander E; Papp LA; Klein DF
    J Psychiatr Res; 1988; 22 Suppl 1():7-31. PubMed ID: 3050060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
    O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P
    J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy complicated by obsessive-compulsive disorder.
    Chelmow D; Halfin VP
    J Matern Fetal Med; 1997; 6(1):31-4. PubMed ID: 9029382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder.
    Fernández-Guasti A; Ulloa RE; Nicolini H
    Psychopharmacology (Berl); 2003 Mar; 166(3):195-201. PubMed ID: 12589517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obsessive compulsive disorder as a cause of atypical eating disorder: a case report.
    Garcia FD; Houy-Durand E; Thibaut F; Dechelotte P
    Eur Eat Disord Rev; 2009 Nov; 17(6):444-7. PubMed ID: 19851993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
    Haffen E; Vandel P; Broly F; Vandel S; Sechter D; Bizouard P; Bechtel PR
    Pharmacopsychiatry; 1999 Nov; 32(6):232-4. PubMed ID: 10599932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obsessions with aggressive content emerging during the course of panic disorder: a different subtype of obsessive-compulsive disorder?
    Fontenelle LF; Mendlowicz MV; Kalaf J; Domingues AM; Versiani M
    Int Clin Psychopharmacol; 2005 Nov; 20(6):343-6. PubMed ID: 16192846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features associated with treatment response in obsessive-compulsive disorder.
    Shavitt RG; Belotto C; Curi M; Hounie AG; Rosário-Campos MC; Diniz JB; Ferrão YA; Pato MT; Miguel EC
    Compr Psychiatry; 2006; 47(4):276-81. PubMed ID: 16769302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An inverse relationship between mania and obsessive-compulsive disorder: a case report.
    Keck PE; Lipinski JF; White K
    J Clin Psychopharmacol; 1986 Apr; 6(2):123-4. PubMed ID: 3084598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.